Evidence map›Paper›PMID 36959613›Full record

ArticleBMC sports science, medicine & rehabilitation2023

Home-based cardio-oncology rehabilitation using a telerehabilitation platform in hematological cancer survivors: a feasibility study.

Katerina Filakova, Andrea Janikova, Marian Felsoci, Filip Dosbaba, Jing Jing Su, Garyfallia Pepera, Ladislav Batalik

Registry-linked trialOpen access · goldFull text read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC sports science, medicine & rehabilitation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04822389 (Effect of the Physical Exercise Training Using Telerehabilitation Among Lymphoma Patients), which is not on this map. Cited by 18 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 3 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04822389 nacompletednot on this map

Effect of the Physical Exercise Training Using Telerehabilitation Among Lymphoma Patients: A Pilot Study

TypeinterventionalSponsorBrno University HospitalRan2021 to 2022Enrolled15ConditionsLymphoma, RehabilitationArmsTelerehablitation using heart rate monitor
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 3 syntheses or guidelines pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Katerina FilakovaDepartment of Rehabilitation, University Hospital Brno, Brno, Czech Republic.ORCID http://orcid.org/0000-0002-4202-3564
Andrea JanikovaDepartment of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.ORCID http://orcid.org/0000-0002-2647-7769
Marian FelsociDepartment of Internal Medicine and Cardiology, University Hospital Brno, Brno, Czech Republic.ORCID http://orcid.org/0000-0002-3829-0467
Filip DosbabaDepartment of Rehabilitation, University Hospital Brno, Brno, Czech Republic.ORCID http://orcid.org/0000-0002-8105-1744
Jing Jing SuSchool of Nursing, The Hong Kong Polytechnic University, Hong Kong, China.ORCID http://orcid.org/0000-0002-8242-811X
Garyfallia PeperaClinical Exercise Physiology and Rehabilitation Research Laboratory, Physiotherapy Department, School of Health Sciences, University of Thessaly, Lamia, Greece.ORCID http://orcid.org/0000-0001-8012-0325
Ladislav BatalikDepartment of Rehabilitation, University Hospital Brno, Brno, Czech Republic. batalik.ladislav@fnbrno.cz.ORCID http://orcid.org/0000-0003-2147-1541
University Hospital Brno · CZCharles University · CZHong Kong Polytechnic University · HKMasaryk University · CZUniversity of Thessaly · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeCardiovascular disease is a competing mortality cause in hematological cancer survivors due to toxic oncological treatment, accumulation of risk factors, and decline of cardiorespiratory fitness. Cardio-oncology rehabilitation (CORE) is an emerging treatment model to optimize the prognosis of hematological cancer patients and survivors; however, its accessibility during the COVID-19 pandemic is poor. The study aimed to evaluate the feasibility, safety, and effect of a 12-week home-based CORE intervention in telerehabilitation approach among hematological cancer survivors.

methodsA prospective single-arm interventional study was conducted at a faculty hospital in Brno, Czech Republic. This study provided 12 weeks of the home-based CORE using a telerehabilitation approach that allows remote supervision by a clinician from a medical facility. The telerehabilitation approach consists of three components: a heart rate sensor (PolarM430, Kempele, Finland), a web platform compatible with the sensor, and telesupervising via telephone call (1 call per week). To improve adherence, a physiotherapist called participants to assess or address adverse effects, exercise feedback, and participant-related concerns. The anthropometry, body composition, and cardiorespiratory fitness were measured immediately after the intervention.

resultsEleven hematological cancer survivors with an average age of 60.3 ± 10 years participated in the study. Most participants were diagnosed with Follicular lymphoma and received maintenance treatment. Participants had a significant (p < 0.05) increase in cardiorespiratory fitness by 2.6 ml/kg/min; and in peak workload, from 143.3 ± 60.6 W to 158.6 ± 67.5 W (p < 0.05). Improvement in anthropometry and body composition was observed but yielded no statistical significance. Most (80%) participants completed the three times/per week telesupervising exercise session for 12 weeks.No adverse event was identified.

conclusionFindings from this study suggest that home-based CORE may provide hematological cancer survivors with an increase in CRF during the rehabilitation period after hospital discharge. The telerehabilitation CORE model is effective, feasible, safe, and has demonstrated good adherence. Further randomized controlled efficacy study with larger sample size is needed before clinical implementation. CLINICAL

trial registrationClinical trial registration number NCT04822389 (30/03/2021).

Indexed as

Cardio-oncology rehabilitationCardiorespiratory fitnessHome-based exerciseTelemonitoringTelerehabilitation

Identifiers

PMID36959613
PMCPMC10034898
OpenAlexW4360615380

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read68
identifiers read1
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.